Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Alkermes

Stocks With Rising Relative Strength: Alkermes

Alkermes shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Alkermes Shows Rising Relative Strength; Still Shy Of Key Benchmark

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

GE Aerospace Leads Five Stocks Near Buy Points With This Bullish Trait

GE Aerospace has formed a flat base, one of several stocks with strong relative strength near buy points and with relatively low volatility.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

On St. Patrick's Day, PDD Holdings and Aon lead five stocks near buy points that are at least a "little Irish."

Investors Business Daily

Alkermes Scores Relative Strength Rating Upgrade; Hits Key Threshold

A Relative Strength Rating upgrade for Alkermes shows improving technical performance.

Investors Business Daily

Alkermes Shows Rising Relative Price Performance; Still Shy Of Key Benchmark

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Alkermes Getting Closer To Key Technical Measure

Alkermes shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

IBD Rating Upgrades: Alkermes Flashes Improved Relative Price Strength

A Relative Strength Rating upgrade for Alkermes shows improving technical performance. Will it continue?

Investors Business Daily

Alkermes Stock Jumps Nearly 30% In 3 Months After Hefty Profits

A Relative Strength Rating upgrade for Alkermes shows improving technical performance. Will it continue?

Investors Business Daily

Alkermes Stock Gets RS Rating Upgrade; Profits Surge

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.

Alkermes stock plummeted to its lowest price since last December on disappointing test results for its experimental narcolepsy treatment.

Investors Business Daily

3 Biotech Stocks to Buy This Month and Beyond

Owing to the critical medical needs, the lookout for new technologies to deal with future advancements is at its peak. Breakthrough innovations, revolutionary treatments, and a booming industry align to make biotech stocks a potential goldmine for savvy investors. Therefore, it could be wise to invest in quality biotech stocks…

StockNews.com

3 Value Stocks Investors Want

Strong recent economic data and still-elevated inflation are expected to keep the Fed on track for another interest rate hike next month. With the stock market likely to remain volatile amid rising interest rates and other macro uncertainties, fundamentally sound stocks Astellas (ALPMY), Alkermes (ALKS), and AstroNova (ALOT), trading at…

StockNews.com

Alkermes Stock Sees Rising Relative Strength Rating

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Alkermes Stock Sees Rising Relative Price Strength

A Relative Strength Rating upgrade for Alkermes shows improving technical performance.

Investors Business Daily

Why Seattle Genetics, Alkermes Are Currently Outperforming Their Peers

Seattle Genetics and Alkermes beat fourth-quarter estimates Thursday, pushing Alkermes stock into a brief breakout as SGEN stock soared.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Change Healthcare (CHNG) Q1 Earnings & Revenues Miss Estimates

Change Healthcare Inc. (NASDAQ: CHNG) reported first-quarter fiscal 2023 adjusted earnings per share (ETF:EPS) of 38 cents, which missed the Zacks Consensus Estimate of 39 cents by 2.6%. The bottom line declined 7.3% on a year-over-year basis.

Investors Business Daily

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Investors Business Daily

IBD Screen Of The Day: Global Stock Leaders Highlight These Top Stocks

A few names from the global stock screen are worth mentioning.

Investors Business Daily

IBD Screen Of The Day: Global Leaders Highlight These Top Health Care Stocks

GSK announced positive results in a late-stage study on a new Covid-19 vaccine targeted to combat the omicron variant.

Investors Business Daily

Global Growth Stocks To Watch On IBD's Screen Of The Day Include Two Oil Stocks

IBD's Screen Of The Day features two oil stocks near buy points. Also, this biotech with excellent earnings made the list.

Benzinga

Looking Into Alkermes's Return On Capital Employed

Benzinga Pro data, Alkermes (NASDAQ:ALKS) reported Q1 sales of $278.55 million. Earnings fell to a loss of $35.90 million, resulting in a 4212.6% decrease from last quarter.

Investors Business Daily

IBD Stock Of The Day Alkermes Breaks Out As Its Newest Drug Snags Big Beat

Alkermes is the IBD Stock Of The Day after strong first-quarter sales of its new bipolar treatment, Lybalvi, led Alkermes stock to break out.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Defense

207 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.